Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products > 55 > 

55-91-4

Products Categories

Basic Information
CAS No.: 55-91-4
Name: DIISOPROPYL FLUOROPHOSPHATE
Article Data: 28
Molecular Structure:
Molecular Structure of 55-91-4 (DIISOPROPYL FLUOROPHOSPHATE)
Formula: C6H14 F O3 P
Molecular Weight: 184.148
Synonyms: Phosphorofluoridicacid, diisopropyl ester (8CI); DFF; DFP; DFP (pesticide); Difluorophate;Diflupyl; Diisopropoxyphosphoryl fluoride; Diisopropyl fluorophosphate;Diisopropyl phosphofluoridate; Diisopropyl phosphorofluoridate; Dyflos;Floropryl; Fluorodiisopropyl phosphate; Fluostigmine; Isoflurophate; Isopropylfluophosphate ((C3H7O)2FPO); Isopropyl phosphorofluoridate ((C3H7O)2FPO);Neoglaucit; O,O-Diisopropyl phosphorofluoridate
EINECS: 200-247-6
Density: 1.079g/cm3
Melting Point: −82 °C(lit.)
Boiling Point: 62 °C9 mm Hg(lit.)
Flash Point: 64.5°C
Solubility: 15.17g/L(25 oC)
Appearance: Colourless Liquid
Hazard Symbols: Cholinesterase inhibitor.
Risk Codes: R26/27/28;
Safety: A poison by ingestion, inhalation, skin contact, intraperitoneal, subcutaneous, intramuscular, ocular, and intravenous routes. Moderately toxic by parenteral route. Human systemic effects by inhalation: miosis (pupillary constriction) and headache. Experimental reproductive effects. Used as a basis for “nerve gases.” An insecticide. Ingestion can cause damage to eyes, nausea, vomiting, diarrhea, and central nervous system disturbances. An FDA proprietary drug. Used as a miotic agent. When heated to decomposition it emits toxic fumes of F and POx. See also PARATHION.
PSA: 45.34000
LogP: 2.91400
  • Display:default sort

    New supplier

  • Total:0 Page 0 of 0
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 55-91-4

Chemistry

IUPAC Name: 2-(Fluoro-isopropoxy-phosphoryl)oxypropane
CAS: 55-91-4
EINECS: 200-247-6
Product Categories: All Inhibitors ; Inhibitors .
Following is the Molecular Structure of Isopropyl phosphorofluoridate (55-91-4):

SMILES: FP(=O)(OC(C)C)OC(C)C
InChI: InChI=1/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3
InChIKey: MUCZHBLJLSDCSD-UHFFFAOYAT
Std.InChI: InChI=1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3
Std.InChIKey: MUCZHBLJLSDCSD-UHFFFAOYSA-N
Molecular Formula: C6H14FO3P
Molecular Weight: 184.15
Melting Point: −82℃(lit.)
Boiling Point: 183℃ at 760mmHg
Flash Point: 64.5℃
Molar Volume: 170.6cm3
Density: 1.079g/cm3
Index of Refraction: 1.388
Molar Refractivity: 40.29cm3
Surface Tension: 26.3dyne/cm
Polarizability: 15.97 10-24cm3
Enthalpy of Vaporization: 40.21kJ/mol
Vapour Pressure: 1.07mmHg at 25℃

Uses

 Isopropyl phosphorofluoridate (55-91-4) can be used as an insecticide,and also used as a potent inhibitor of serine Proteases such as Trypsin and Chymotrypsin , and of Acetylcholinesterase .Used in Germany as a basis for "nerve gases".

Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 intravenous 1700ug/kg (1.7mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

CARDIAC: OTHER CHANGES

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 400, 1946.
cat LD50 oral 1600mg/kg (1600mg/kg)   Deutsche Gesundheitswesen. Vol. 15, Pg. 2179, 1960.
dog LD50 intravenous 3430ug/kg (3.43mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: ATAXIA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 414, 1946.
dog LD50 subcutaneous 3mg/kg (3mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 414, 1946.
dog LDLo intramuscular 3mg/kg (3mg/kg) PERIPHERAL NERVE AND SENSATION: FASCICULATIONS

BEHAVIORAL: TREMOR
Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 421, 1946.
domestic animals - goat/sheep LD50 intravenous 800ug/kg (0.8mg/kg) BEHAVIORAL: COMA

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
National Technical Information Service. Vol. PB158-508,
domestic animals - goat/sheep LD50 subcutaneous 1mg/kg (1mg/kg) BEHAVIORAL: COMA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
National Technical Information Service. Vol. PB158-508,
frog LD50 parenteral 1450mg/kg (1450mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 124, Pg. 212, 1960.
human TCLo inhalation 8200ug/m3/10M (8.2mg/m3) SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE

BEHAVIORAL: HEADACHE
National Technical Information Service. Vol. PB158-508,
man LDLo intramuscular 480ug/kg (0.48mg/kg)   Journal of Clinical Investigation. Vol. 37, Pg. 350, 1958.
man LDLo oral 2100ug/kg (2.1mg/kg)   Journal of Clinical Investigation. Vol. 37, Pg. 350, 1958.
monkey LD50 intravenous 100ug/kg (0.1mg/kg)   National Technical Information Service. Vol. PB158-508,
monkey LD50 subcutaneous 1mg/kg (1mg/kg)   Deutsche Gesundheitswesen. Vol. 15, Pg. 2179, 1960.
monkey LDLo intramuscular 200ug/kg (0.2mg/kg) PERIPHERAL NERVE AND SENSATION: FASCICULATIONS

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 421, 1946.
mouse LC50 inhalation 440mg/m3/10M (440mg/m3) SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE Nature. Vol. 157, Pg. 287, 1946.
mouse LD50 intraperitoneal 2450ug/kg (2.45mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: TREMOR

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Archivum Immunologiae et Therapiae Experimentalis. Vol. 23, Pg. 769, 1975.
mouse LD50 intravenous 3200ug/kg (3.2mg/kg)   Biochemical Pharmacology. Vol. 15, Pg. 169, 1966.
mouse LD50 oral 2mg/kg (2mg/kg)   National Technical Information Service. Vol. PB158-508,
mouse LD50 skin 72mg/kg (72mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 414, 1946.
mouse LD50 subcutaneous 3mg/kg (3mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: CYANOSIS
Journal of Pharmacy and Pharmacology. Vol. 34, Pg. 603, 1982.
mouse LD50 unreported 5mg/kg (5mg/kg)   Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 239, Pg. 126, 1960.
rabbit LD50 intramuscular 750ug/kg (0.75mg/kg)   National Technical Information Service. Vol. PB158-508,
rabbit LD50 intravenous 300ug/kg (0.3mg/kg)   National Technical Information Service. Vol. PB158-508,
rabbit LD50 ocular 1150ug/kg (1.15mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 414, 1946.
rabbit LD50 oral 4mg/kg (4mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 414, 1946.
rabbit LD50 skin > 117mg/kg (117mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 414, 1946.
rabbit LD50 subcutaneous 1mg/kg (1mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 414, 1946.
rat LC50 inhalation 360mg/m3/10M (360mg/m3) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Journal of the Chemical Society. Vol. -, Pg. 695, 1948.
rat LD50 intramuscular 1800ug/kg (1.8mg/kg)   Journal of Clinical Investigation. Vol. 37, Pg. 350, 1958.
rat LD50 intraperitoneal 1280ug/kg (1.28mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Arzneimittel-Forschung. Drug Research. Vol. 14, Pg. 85, 1964.
rat LD50 oral 5mg/kg (5mg/kg)   National Technical Information Service. Vol. PB158-508,
rat LD50 subcutaneous 1440ug/kg (1.44mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 226, Pg. 302, 1977.

Consensus Reports

EPA Extremely Hazardous Substances List. Reported in EPA TSCA Inventory.

Safety Profile

Hazard Codes:  T+ Very Toxic, Xi Irritant. 
Risk Statements: 26/27/28-36/37/38
R26/27/28: Very Toxic by inhalation, in contact with skin and if swallowed.
R36/37/38: Irritating to eyes, respiratory system and skin.
Safety Statements: 36/37/39-45-36/37-26
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.
S45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible).
S36/37: Wear suitable protective clothing and gloves.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
RIDADR: UN 3382 6.1/PG 1
WGK: Germany 3
RTECS: TE5075000
F: 10-21
HazardClass: 6.1(a)
PackingGroup: I
A poison by ingestion, inhalation, skin contact, intraperitoneal, subcutaneous, intramuscular, ocular, and intravenous routes. Moderately toxic by parenteral route. Human systemic effects by inhalation: miosis (pupillary constriction) and headache. Experimental reproductive effects. Used as a basis for "nerve gases."Ingestion can cause damage to eyes, nausea, vomiting, diarrhea, and central nervous system disturbances.An FDA proprietary drug. Used as a miotic agent.

Specification

 Isopropyl phosphorofluoridate (55-91-4),which also can be called for Diflupyl ; Diflurophate ; Diisopropoxyphosphoryl fluoride ; Diisopropoxyphosphorylfluoride ; Diisopropyl fluoridophosphate ; Diisopropyl fluorophosphonate ; Diisopropyl phosphofluoridate ; Diisopropylfluorfosfat .
Isopropyl phosphorofluoridate (55-91-4) is a clear and colourless liquid.This is an organophosphate pesticide.When Isopropyl phosphorofluoridate (55-91-4) was heated,it emits toxic fumes of F− and POx .This chemical will decompose in water at pH about 2.5.Be attention of this chemical is extremely toxic.